Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1
Krzysztof Marycz,1,2 Agnieszka Smieszek,1 Klaudia Marcinkowska,1 Mateusz Sikora,1 Eliza Turlej,1 Paulina Sobierajska,3 Adrian Patej,3 Alina Bienko,4 Rafal J Wiglusz3 1The Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences, Wro...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/0ba2e6adf0e84ec480d69bb41fbfc251 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:0ba2e6adf0e84ec480d69bb41fbfc251 |
|---|---|
| record_format |
dspace |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
nanocomposites hydroxyapatite osteoblasts osteoclasts osteoporosis Medicine (General) R5-920 |
| spellingShingle |
nanocomposites hydroxyapatite osteoblasts osteoclasts osteoporosis Medicine (General) R5-920 Marycz K Smieszek A Marcinkowska K Sikora M Turlej E Sobierajska P Patej A Bienko A Wiglusz RJ Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1 |
| description |
Krzysztof Marycz,1,2 Agnieszka Smieszek,1 Klaudia Marcinkowska,1 Mateusz Sikora,1 Eliza Turlej,1 Paulina Sobierajska,3 Adrian Patej,3 Alina Bienko,4 Rafal J Wiglusz3 1The Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences, Wroclaw, Poland; 2International Institute of Translational Medicine, Malin, Poland; 3Institute of Low Temperature and Structure Research, PAS, Wroclaw, Poland; 4Faculty of Chemistry, University of Wroclaw, Wroclaw, PolandCorrespondence: Krzysztof MaryczThe Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences Wroclaw, Norwida 27B St, Wroclaw, 50– 375, PolandTel +48 71 320 5201Email krzysztof.marycz@upwr.edu.plPurpose: Osteoporosis results in a severe decrease in the life quality of many people worldwide. The latest data shows that the number of osteoporotic fractures is becoming an increasing international health service problem. Therefore, a new kind of controllable treatment methods for osteoporotic fractures is extensively desired. For that reason, we have manufactured and evaluated nanohydroxyapatite (nHAp)-based composite co-doped with iron oxide (IO) nanoparticles. The biomaterial was used as a matrix for the controlled delivery of miR-21-5p and miR-124-3p, which have a proven impact on bone cell metabolism.Methods: The nanocomposite Ca5(PO4)3OH/Fe3O4 (later called nHAp/IO) was obtained by the wet chemistry method and functionalised with microRNAs (nHAp/IO@miR-21/124). Its physicochemical characterization was performed using XRPD, FT-IR, SEM-EDS and HRTEM and SAED methods. The modulatory effect of the composite was tested in vitro using murine pre-osteoblasts MC3T3-E1 and pre-osteoclasts 4B12. Moreover, the anti-inflammatory effects of biomaterial were analysed using a model of LPS-treated murine macrophages RAW 264.7. We have analysed the cells’ viability, mitochondria membrane potential and oxidative stress under magnetic field (MF+) and without (MF-). Moreover, the results were supplemented with RT-qPCR and Western blot assays to evaluate the expression profile for master regulators of bone metabolism.Results: The results indicated pro-osteogenic effects of nHAp/IO@miR-21/124 composite enhanced by exposure to MF. The enhanced osteogenesis guided by nHAp/IO@miR-21/124 presence was associated with increased metabolism of progenitor cells and activation of osteogenic markers (Runx-2, Opn, Coll-1). Simultaneously, nanocomposite decreased metabolism and differentiation of pre-osteoclastic 4B12 cells accompanied by reduced expression of CaII and Ctsk. Obtained composite regulated viability of bone progenitor cells and showed immunomodulatory properties inhibiting the expression of inflammatory markers, ie, TNF-α, iNOs or IL-1β, in LPS-stimulated RAW 264.7 cells.Conclusion: We have described for the first time a new concept of osteoporosis treatment based on nHAp/IO@miR-21/124 application. Obtained results indicated that fabricated nanocomposite might impact proper regeneration of osteoporotic bone, restoring the balance between osteoblasts and osteoclast.Keywords: nanocomposites, hydroxyapatite, osteoblasts, osteoclasts, osteoporosis |
| format |
article |
| author |
Marycz K Smieszek A Marcinkowska K Sikora M Turlej E Sobierajska P Patej A Bienko A Wiglusz RJ |
| author_facet |
Marycz K Smieszek A Marcinkowska K Sikora M Turlej E Sobierajska P Patej A Bienko A Wiglusz RJ |
| author_sort |
Marycz K |
| title |
Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1 |
| title_short |
Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1 |
| title_full |
Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1 |
| title_fullStr |
Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1 |
| title_full_unstemmed |
Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1 |
| title_sort |
nanohydroxyapatite (nhap) doped with iron oxide nanoparticles (io), mir-21 and mir-124 under magnetic field conditions modulates osteoblast viability, reduces inflammation and inhibits the growth of osteoclast – a novel concept for osteoporosis treatment: part 1 |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/0ba2e6adf0e84ec480d69bb41fbfc251 |
| work_keys_str_mv |
AT maryczk nanohydroxyapatitenhapdopedwithironoxidenanoparticlesiomir21andmir124undermagneticfieldconditionsmodulatesosteoblastviabilityreducesinflammationandinhibitsthegrowthofosteoclastndashanovelconceptforosteoporosistreatmentpart1 AT smieszeka nanohydroxyapatitenhapdopedwithironoxidenanoparticlesiomir21andmir124undermagneticfieldconditionsmodulatesosteoblastviabilityreducesinflammationandinhibitsthegrowthofosteoclastndashanovelconceptforosteoporosistreatmentpart1 AT marcinkowskak nanohydroxyapatitenhapdopedwithironoxidenanoparticlesiomir21andmir124undermagneticfieldconditionsmodulatesosteoblastviabilityreducesinflammationandinhibitsthegrowthofosteoclastndashanovelconceptforosteoporosistreatmentpart1 AT sikoram nanohydroxyapatitenhapdopedwithironoxidenanoparticlesiomir21andmir124undermagneticfieldconditionsmodulatesosteoblastviabilityreducesinflammationandinhibitsthegrowthofosteoclastndashanovelconceptforosteoporosistreatmentpart1 AT turleje nanohydroxyapatitenhapdopedwithironoxidenanoparticlesiomir21andmir124undermagneticfieldconditionsmodulatesosteoblastviabilityreducesinflammationandinhibitsthegrowthofosteoclastndashanovelconceptforosteoporosistreatmentpart1 AT sobierajskap nanohydroxyapatitenhapdopedwithironoxidenanoparticlesiomir21andmir124undermagneticfieldconditionsmodulatesosteoblastviabilityreducesinflammationandinhibitsthegrowthofosteoclastndashanovelconceptforosteoporosistreatmentpart1 AT pateja nanohydroxyapatitenhapdopedwithironoxidenanoparticlesiomir21andmir124undermagneticfieldconditionsmodulatesosteoblastviabilityreducesinflammationandinhibitsthegrowthofosteoclastndashanovelconceptforosteoporosistreatmentpart1 AT bienkoa nanohydroxyapatitenhapdopedwithironoxidenanoparticlesiomir21andmir124undermagneticfieldconditionsmodulatesosteoblastviabilityreducesinflammationandinhibitsthegrowthofosteoclastndashanovelconceptforosteoporosistreatmentpart1 AT wigluszrj nanohydroxyapatitenhapdopedwithironoxidenanoparticlesiomir21andmir124undermagneticfieldconditionsmodulatesosteoblastviabilityreducesinflammationandinhibitsthegrowthofosteoclastndashanovelconceptforosteoporosistreatmentpart1 |
| _version_ |
1718385252851777536 |
| spelling |
oai:doaj.org-article:0ba2e6adf0e84ec480d69bb41fbfc2512021-12-02T16:00:43ZNanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 11178-2013https://doaj.org/article/0ba2e6adf0e84ec480d69bb41fbfc2512021-05-01T00:00:00Zhttps://www.dovepress.com/nanohydroxyapatite-nhap-doped-with-iron-oxide-nanoparticles-io-mir-21--peer-reviewed-fulltext-article-IJNhttps://doaj.org/toc/1178-2013Krzysztof Marycz,1,2 Agnieszka Smieszek,1 Klaudia Marcinkowska,1 Mateusz Sikora,1 Eliza Turlej,1 Paulina Sobierajska,3 Adrian Patej,3 Alina Bienko,4 Rafal J Wiglusz3 1The Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences, Wroclaw, Poland; 2International Institute of Translational Medicine, Malin, Poland; 3Institute of Low Temperature and Structure Research, PAS, Wroclaw, Poland; 4Faculty of Chemistry, University of Wroclaw, Wroclaw, PolandCorrespondence: Krzysztof MaryczThe Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences Wroclaw, Norwida 27B St, Wroclaw, 50– 375, PolandTel +48 71 320 5201Email krzysztof.marycz@upwr.edu.plPurpose: Osteoporosis results in a severe decrease in the life quality of many people worldwide. The latest data shows that the number of osteoporotic fractures is becoming an increasing international health service problem. Therefore, a new kind of controllable treatment methods for osteoporotic fractures is extensively desired. For that reason, we have manufactured and evaluated nanohydroxyapatite (nHAp)-based composite co-doped with iron oxide (IO) nanoparticles. The biomaterial was used as a matrix for the controlled delivery of miR-21-5p and miR-124-3p, which have a proven impact on bone cell metabolism.Methods: The nanocomposite Ca5(PO4)3OH/Fe3O4 (later called nHAp/IO) was obtained by the wet chemistry method and functionalised with microRNAs (nHAp/IO@miR-21/124). Its physicochemical characterization was performed using XRPD, FT-IR, SEM-EDS and HRTEM and SAED methods. The modulatory effect of the composite was tested in vitro using murine pre-osteoblasts MC3T3-E1 and pre-osteoclasts 4B12. Moreover, the anti-inflammatory effects of biomaterial were analysed using a model of LPS-treated murine macrophages RAW 264.7. We have analysed the cells’ viability, mitochondria membrane potential and oxidative stress under magnetic field (MF+) and without (MF-). Moreover, the results were supplemented with RT-qPCR and Western blot assays to evaluate the expression profile for master regulators of bone metabolism.Results: The results indicated pro-osteogenic effects of nHAp/IO@miR-21/124 composite enhanced by exposure to MF. The enhanced osteogenesis guided by nHAp/IO@miR-21/124 presence was associated with increased metabolism of progenitor cells and activation of osteogenic markers (Runx-2, Opn, Coll-1). Simultaneously, nanocomposite decreased metabolism and differentiation of pre-osteoclastic 4B12 cells accompanied by reduced expression of CaII and Ctsk. Obtained composite regulated viability of bone progenitor cells and showed immunomodulatory properties inhibiting the expression of inflammatory markers, ie, TNF-α, iNOs or IL-1β, in LPS-stimulated RAW 264.7 cells.Conclusion: We have described for the first time a new concept of osteoporosis treatment based on nHAp/IO@miR-21/124 application. Obtained results indicated that fabricated nanocomposite might impact proper regeneration of osteoporotic bone, restoring the balance between osteoblasts and osteoclast.Keywords: nanocomposites, hydroxyapatite, osteoblasts, osteoclasts, osteoporosisMarycz KSmieszek AMarcinkowska KSikora MTurlej ESobierajska PPatej ABienko AWiglusz RJDove Medical PressarticlenanocompositeshydroxyapatiteosteoblastsosteoclastsosteoporosisMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 3429-3456 (2021) |